PRF Technologies Ltd.
- PRFX
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Post-Surgical Pain Management
- Clinical-Stage Pharmaceuticals
$0.74
Today −5.26%Quote Oct 19, 2026, 04:03 PM UTC
−23.39%over the last month
Max drawdown −23.4%From 1-month high −23.4%3 months −32.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About PRF Technologies
PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
7
Founded
2007
Market value
$614,902.804
Quote Oct 19
Resistance
$0.77
3.5% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PRFXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free